Anthony Pompliano

Bitcoin, obviously, you guys could build an amazing business by going in, you know, quadrupling assets over the next couple of years.

You also are pushing horizontally, though, and offering other funds and thinking about tokenization and all these other things.

So how do you think about press your advantage on the Bitcoin ETF, but also build, you know, kind of diversified portfolio or diversified business?

Dan, you're bringing venture exposure to an institutional audience.

No, not venture.

No, we don't do venture growth.

Growth.

Well, you wouldn't consider the growth investing as a kind of a broader venture where there's early venture and late stage venture?

Robbie, I have been fond of saying or maybe posturing the question, is BlackRock a Bitcoin company, not a traditional finance company?

Like at some point there is this, you know, like you guys are so successful with the product.

If it is the most profitable, it is the largest revenue driver.

People from the crypto world would be proud to say, hey, we're a crypto company.

Traditional finance is a little bit different.

You almost want to come at it and be a traditional finance company who is helping the institutional world adopt this new asset.

But when you look forward, I've got to imagine people internally are like, hey,

there's new clients, there's new assets, there's new revenue coming from this sector.

So how do you guys think about, you know, the evolution of digital asset strategy inside of the company?

And is it a thing where you keep building the traditional, you know, side, but digital assets just grows faster and eventually maybe it's, you know, 25% or so of the internal business or like, how are you guys looking at this?

No guesswork and no blind spots.

From there, they create a personalized plan that prevents disease and may even reverse aging using precision medicine and restorative therapeutics.